Short answer: No — not every nitrile glove is appropriate for chemotherapy administration. Suitability for cytotoxic drug handling depends on whether the finished glove has been tested to ASTM D6978, the standard practice that measures permeation of specific chemotherapy drugs through the intact glove film, rather than ASTM D6319, which covers general nitrile examination gloves. A glove labelled only as a nitrile examination glove is a barrier for routine clinical contact, but it becomes a documented chemotherapy barrier only when D6978 testing appears on the packaging or technical data sheet.
Quick Facts
- ASTM D6978 is the standard practice for testing medical glove resistance to permeation by chemotherapy drugs.
- ASTM D6319 is the nitrile examination glove specification — dimensions, tensile properties, watertightness. It does not evaluate chemotherapy permeation.
- Penetration ≠ permeation. A glove can pass a watertightness (pinhole) check and still let a drug migrate through the polymer.
- D6978 results are drug-specific, reported as a breakthrough detection time in minutes per drug.
- Chemo-rated nitrile is usually 4 mil or thicker with an extended cuff; thickness alone creates no documentation claim.
- Double-gloving and defined change intervals are operational controls layered alongside glove selection.
Why "Nitrile" Describes the Material, Not the Barrier
Nitrile is a synthetic rubber family. Two gloves made from the same polymer family can behave very differently against a cytotoxic drug, because performance depends on formulation, film thickness, cure and — critically — whether the finished device was tested against drug formulations at all. Barrier performance is a property of the finished device, not of the word printed on the box.
A purchasing decision for chemotherapy handling should start with the standard named on the label, not the material name. Our clinical learning hub collects the definitions buyers ask about most.
What ASTM D6978 Actually Tests
ASTM D6978 is a standard practice for the assessment of resistance of medical gloves to permeation by chemotherapy drugs. It is not a pass-or-fail stamp that a glove either wins or loses; it is a laboratory method that produces drug-specific results. A glove is properly described as tested when documented results exist for the drugs relevant to your site.
Penetration vs. permeation: two different failure modes
Penetration is the movement of a liquid through a hole, pore or physical defect. That is the failure mode pinhole watertightness testing and AQL sampling are designed to catch — see our explainer on nitrile glove pinhole testing and AQL levels for Canadian clinics for how those acceptance levels are set.
Permeation is different: a chemical travels through an intact film at a molecular level, with no visible hole and no leak to detect. A glove can pass a watertightness test and still allow a chemotherapy drug to migrate through the polymer over a period of contact. ASTM D6978 addresses that second failure mode.
What the test reports
In a permeation cell, the glove film separates a challenge solution containing the drug from a collection medium. The laboratory measures how long it takes before the drug is detected on the collection side, and reports a breakthrough detection time, normally in minutes, for each drug tested. Longer times indicate a greater margin of protection, and a chemo-documented glove normally carries results for the drugs your site handles rather than a generic chemical-resistance sentence.
ASTM D6978 vs. ASTM D6319: Why the Distinction Matters
The two standards sit at different levels of the glove quality story, and that is where purchasing errors begin. ASTM D6319 is a specification: it defines minimum construction, dimension and strength requirements plus a watertightness test a production lot must meet. ASTM D6978 is a practice: it describes how permeation testing is performed and reported. A glove can satisfy one and not the other.
| Attribute | ASTM D6319 (nitrile exam glove) | ASTM D6978 (chemo permeation) |
|---|---|---|
| Document type | Standard specification | Standard practice / test method |
| What it evaluates | Dimensions, tensile properties, watertightness | Permeation of specific chemotherapy drugs through the film |
| Typical output | Pass / fail against minimum requirements | Breakthrough detection time (minutes) per drug |
| Failure mode addressed | Penetration through holes and defects | Chemical migration through intact material |
| Label language | Nitrile examination glove | Tested to ASTM D6978, or chemotherapy-tested |
| Buyer takeaway | Necessary for routine clinical use | Necessary add-on before cytotoxic handling |
How to Read a Glove Label Before You Buy for Chemo Handling
Ask for documentation, not adjectives. A sheet saying "chemical resistant" tells you nothing you can audit. Work through four checks in order.
- Standard number. Look for the ASTM designation on the box or technical data sheet. D6978 is the one that speaks to chemotherapy permeation.
- Drug list. Permeation results should name the drugs tested. If your drugs are absent from the panel, ask how the glove was qualified for that use.
- Reported times. Breakthrough detection times per drug are more informative than a checkbox, and should be traceable to a test report.
- Lot and shelf life. Elastomer properties can shift in storage; confirm lot traceability and expiry convention.
If your organization requires supplier qualifications beyond glove standards — registration status, quality system evidence, product documentation — our certifications and compliance overview shows the paperwork set we maintain and can share with procurement teams.
Double-Gloving: The Convention and the Limits
Double-gloving means wearing two pairs at once, typically an inner pair and an outer pair. It is a long-standing convention in hazardous drug handling guidance, including the NIOSH hazardous drug list and USP General Chapter <800>, because it stacks a second barrier behind the first.
Why two pairs
If the outer glove is contaminated, torn or compromised, the inner glove still separates skin from the drug. The inner glove also lowers the chance of skin contact during doffing, when the fingers of one hand slide under the cuff of the other. Some facilities pair a thinner inner glove with a thicker outer glove to balance tactile feedback against protection.
When to change gloves
Change immediately after a known contact with a drug, after any spill response, after removing contaminated PPE, and after a tear or visible contamination. Routine changes follow the interval your facility's hazardous drug handling policy defines, since that policy reflects your drug list, tasks and local obligations. For buyers, glove change is a consumable-planning variable: a strict interval consumes far more gloves per shift than changing only on visible soiling.
Thickness, Length and Fit: Practical Selection Notes
Chemotherapy-tested nitrile gloves are commonly 4 mil or heavier, with cuffs long enough to cover the wrist below a gown cuff. Heavier films generally extend the permeation margin, one reason 6 mil heavy-duty black nitrile gloves are often kept for compounding and spill work where tactile delicacy is less critical.
For gloves carrying both sensitivity and chemo documentation, the 4.0 mil powder-free chemo-grade nitrile examination gloves are a reasonable reference when comparing quotations, since 4 mil is a common floor for cytotoxic tasks. Powder-free construction removes a separate variable in clean-handling environments; see our powdered vs. powder-free nitrile glove comparison. Cuff length and fingertip sensitivity matter most with fine instrumentation, the focus of our exam gloves for phlebotomy guide — the same tactile considerations apply when feeling a port or needle connection through a glove.
Common Purchasing Mistakes
- Treating "nitrile" as a specification. Material family answers what the glove is made of, not what it was tested against.
- Assuming thicker equals chemo-rated. A heavy glove with no D6978 data is still an undocumented barrier for cytotoxic work.
- Single-SKU standardisation across departments. One glove for examination rooms and hazardous drug handling usually lets the tighter budget drive the choice, and the higher-risk task inherits the weaker documentation.
- Ignoring the change interval in the consumption forecast. Double-gloving with a defined change schedule can multiply glove usage per case compared with routine examination use.
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.
Related reading
Continue with nitrile glove pinhole testing and AQL levels for Canadian clinics, powdered vs. powder-free nitrile glove comparison and exam gloves for phlebotomy guide.
Frequently Asked Questions
Are all nitrile gloves appropriate for chemotherapy administration?
No. Only gloves with documented ASTM D6978 permeation testing for the relevant drugs should be treated as chemotherapy barriers. A nitrile glove meeting ASTM D6319 suits routine clinical contact, but examination-glove testing does not evaluate chemotherapy drug permeation.
What does ASTM D6978 actually measure?
It measures permeation — migration of a chemotherapy drug through intact glove material at a molecular level. Testing reports a breakthrough detection time in minutes per drug, rather than a single pass or fail result.
Is a thicker nitrile glove automatically chemotherapy-rated?
No. Thickness influences how long a drug takes to permeate, but a rating comes from testing and documentation, not the millimetre figure on the box. A 6 mil glove with no D6978 results is still an unverified barrier.
How often should chemotherapy gloves be changed?
Change gloves after a known drug contact, after spill response, after removing contaminated PPE, and after a tear. Routine intervals should follow your facility's hazardous drug policy, which reflects your drug list and tasks.
Should chemotherapy gloves always be worn double?
Double-gloving is a common convention in hazardous drug handling guidance because it adds a second barrier and reduces exposure during doffing. Whether a specific task requires it depends on your facility's policy and risk assessment.
Before your next glove reorder, confirm the D6978 payload, not just the polymer. Ask your supplier for the drug-specific permeation report for the agents your team handles, and match glove thickness and cuff length to the task rather than to habit.
Ready to standardise? → Start with a trial: CliniEco 24h Biological Indicator — 5-Pack Trial
CliniEco Medical is a licensed medical device establishment (MDEL #35334). This article is educational technical information about glove standards and does not replace your facility's hazardous drug handling policy, occupational health and safety training, or any provincial requirements that apply to your site.
Related Reading
Explore more guides in this category:
0 commentaire